Document is current

Article History

Received: 4 November 2021

Accepted: 31 January 2022

First Online: 22 February 2022

Declarations

:

: CS reports institutional research grants from BMS Stiftung Immunonkologie outside the submitted work. IB received speaker fees from Novartis, Bayer, Pfizer, Takeda and AstraZeneca and honoraria for advisory board participation from BMS and Novartis, outside the submitted work. TE served as consultant for Sanofi, Novartis, Bristol-Myers Squibb, MSD, Almiral Hermal, and Pierre Fabre, outside the submitted work. TA served as consultant to BMS, Novartis and CeCaVa; received honoraria or travel support from BMS, Novartis, Pierre Fabre and CeCaVa, outside the submitted work. LF reported grants from the Swiss National Science Foundation, Swiss Cancer League, Hookipa Pharma, Krebsliga Schweiz, and Novartis Foundation as well as an advisory role for Novartis, Sanofi and Bristol-Myers Squibb, outside the submitted work.CG reports personal fees from Amgen, personal fees from MSD, grants and personal fees from Novartis, grants and personal fees from NeraCare, grants and personal fees from BMS, personal fees from Philogen, grants and personal fees from Roche, grants and personal fees from Sanofi, outside the submitted work. AF served as consultant to Roche, Novartis, MSD, BMS, Pierre-Fabre; received travel support from Roche, Novartis, BMS, Pierre-Fabre, received speaker fees from Roche, Novartis, BMS, MSD and CeGaT, outside the submitted work. She reports institutional research grants from BMS Stiftung Immunonkologie outside the submitted work. The other authors report no conflict of interest.

: The study was approved by the local Ethics Committee of the University of Tübingen (project number 606/2020BO).